HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Disposition of cyproheptadine in cats after intravenous or oral administration of a single dose.

AbstractOBJECTIVE:
To determine disposition of cyproheptadine hydrochloride in cats after intravenous or oral administration of a single dose.
ANIMALS:
6 healthy cats.
PROCEDURE:
A randomized crossover design was used, and each cat was studied after intravenous (2 mg) and oral (8 mg) administration of cyproheptadine. Blood samples were collected at fixed time intervals after drug administration, and serum cyproheptadine concentration was determined by means of polarized immunofluorescence.
RESULTS:
Mean (+/- SD) residence time was significantly longer after oral (823 +/- 191 minutes) than after intravenous (339 +/- 217 minutes) administration, but no significant differences were detected between other pharmacokinetic parameters after oral and intravenous administration. Mean +/- SD oral bioavailability was 1.01 +/- 0.36. Mean elimination half-life after oral administration was 12.8 +/- 9.9 hours. Peak extrapolated cyproheptadine concentration was 669 +/- 206 ng/ml. Only 1 cat developed adverse effects (transient vocalization).
CONCLUSIONS:
Cyproheptadine appeared to be well tolerated in cats and had high bioavailability after oral administration. The mean elimination half-life of 12 hours indicated that approximately 2.5 days must elapse to achieve steady-state concentrations of cyproheptadine after oral administration of multiple doses. A 12-hour dosing interval is acceptable, but an 8-hour interval may be indicated for some cats.
CLINICAL RELEVANCE:
On the basis of pharmacokinetic parameters determined in this study, the oral form of cyproheptadine appears to be suitable for use in clinical trials to treat anorexia in cats. Its half-life is compatible with once or twice daily dosing.
AuthorsC R Norris, D M Boothe, T Esparza, C Gray, M Ragsdale
JournalAmerican journal of veterinary research (Am J Vet Res) Vol. 59 Issue 1 Pg. 79-81 (Jan 1998) ISSN: 0002-9645 [Print] United States
PMID9442249 (Publication Type: Journal Article)
Chemical References
  • Cyproheptadine
Topics
  • Administration, Oral
  • Animals
  • Cats
  • Cyproheptadine (administration & dosage, blood, pharmacokinetics)
  • Half-Life
  • Injections, Intravenous
  • Male
  • Metabolic Clearance Rate
  • Models, Biological

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: